Canaccord Genuity Boosts Cree (CREE) PT to $37
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/3/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Piper Jaffray Assumes Cree (CREE) at Overweight
January 23, 2013 7:56 AM ESTPiper Jaffray assumes coverage on Cree (NASDAQ: CREE) with a Overweight. PT $43.00.
For an analyst ratings summary and ratings history on Cree click here. For more ratings news on Cree click here.
Shares of Cree closed at $33.47 yesterday, with a 52 week range of $22.25-$35.09.... More
Needham & Company Lifts PT on Cree (CREE) on 'Strong' Q2
January 23, 2013 7:43 AM ESTNeedham & Company raised its price target on Buy-rated Cree (NASDAQ: CREE) from $36 to $42 post Q2.
The firm comments, "CREE reported a strong F2Q13 (Dec) and provided guidance above the Streets estimates. The top-line growth and continued margin expansion in both the LED... More
Cree, Inc. (CREE) Tops Q2 EPS by 2c; Guides Q3 EPS, Revs Above
January 22, 2013 4:01 PM ESTCree, Inc. (NASDAQ: CREE) reported Q2 EPS of $0.32, $0.02 better than the analyst estimate of $0.30. Revenue for the quarter came in at $346.3 million versus the consensus estimate of $331.2 million.
Cree, Inc. sees Q3 2013 EPS of $0.30-0.35, versus the consensus of $0.28. Cree, Inc. sees Q3 2013... More

